Magnesium Supplement Bioavailability & Efficacy Simulator

Pharmacological Kinetics & Clinical RCT Evidence Matrix

Presets:

1. Parameter Configuration

350 mg
50 mg 350 mg (RDA) 600 mg

Stoichiometric Conversion

Total Salt Mass Required 2,482 mg
Elemental Mg % 14.1%
To achieve 350 mg of elemental magnesium using Mg Glycinate, a total compound pill mass of 2,482 mg is required due to the glycine carrier weight.

24-Hour Systemic Plasma Concentration Dynamics

Simulated plasma levels over 24 hours post-ingestion (mg/L increase above baseline)

Peak: +0.48 mg/L @ 3.5h
BBB Penetration Index 8.8 / 10

High central nervous system uptake. Active transporter cross-rate optimized for synaptic tissue enrichment.

GI Osmotic Distress Index 12 / 100 (Low Risk)

Cheated organic structure prevents intestinal water draw, minimizing laxative or osmotic distress risk.

RCT Clinical Trial Evidence Mapping

Grade A Evidence
Primary Endpoint

Sleep Latency Reduction

-18.4 min average
Observed Bioavailability

High (Organic Chelate)

~24% absorption
Recommended Dose Range

200 - 400 mg / day

Evening administration

Clinical trials demonstrate that organic amino-acid chelated magnesium (e.g., Glycinate) significantly reduces GABA-ergic inhibition thresholds, accelerating sleep onset latency without inducing osmotic intestinal distress.

Ref: Abbasi et al. (2012) J Res Med Sci; Nielsen et al. (2010) Magnes Res.

Enjoy this tool? Build your own with Super